Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells.

Autor: Dean MJ; Louisiana State University Cancer Center, New Orleans, LA, United States., Ochoa JB; Department of Surgery, Ochsner Medical Center, New Orleans, LA, United States., Sanchez-Pino MD; Louisiana State University Cancer Center, New Orleans, LA, United States.; Department of Genetics, LSU Health, New Orleans, LA, United States., Zabaleta J; Louisiana State University Cancer Center, New Orleans, LA, United States.; Department of Pediatrics, LSU Health, New Orleans, LA, United States., Garai J; Louisiana State University Cancer Center, New Orleans, LA, United States., Del Valle L; Louisiana State University Cancer Center, New Orleans, LA, United States.; Department of Pathology LSU Health, New Orleans, LA, United States., Wyczechowska D; Louisiana State University Cancer Center, New Orleans, LA, United States., Baiamonte LB; Tissue Biorepository, Ochsner Medical Center, New Orleans, LA, United States., Philbrook P; Louisiana State University Cancer Center, New Orleans, LA, United States.; Department of Genetics, LSU Health, New Orleans, LA, United States., Majumder R; Department of Biochemistry, LSU Health, New Orleans, LA, United States., Vander Heide RS; Department of Pathology LSU Health, New Orleans, LA, United States., Dunkenberger L; Louisiana State University Cancer Center, New Orleans, LA, United States., Thylur RP; Louisiana State University Cancer Center, New Orleans, LA, United States., Nossaman B; Department of Surgery, Ochsner Medical Center, New Orleans, LA, United States., Roberts WM; Department of Internal Medicine, Ochsner Medical Center, New Orleans, LA, United States., Chapple AG; Louisiana State University Cancer Center, New Orleans, LA, United States.; School of Public Health, LSU Health, New Orleans, LA, United States., Wu J; Department of Genetics, LSU Health, New Orleans, LA, United States., Hicks C; Department of Genetics, LSU Health, New Orleans, LA, United States., Collins J; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Luke B; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Johnson R; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Koul HK; Louisiana State University Cancer Center, New Orleans, LA, United States.; Department of Biochemistry, LSU Health, New Orleans, LA, United States., Rees CA; Division of Emergency Medicine, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, United States., Morris CR; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, Children's Healthcare of Atlanta, Atlanta, GA, United States., Garcia-Diaz J; Tissue Biorepository, Ochsner Medical Center, New Orleans, LA, United States., Ochoa AC; Louisiana State University Cancer Center, New Orleans, LA, United States.; Department of Pediatrics, LSU Health, New Orleans, LA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2021 Jul 14; Vol. 12, pp. 695972. Date of Electronic Publication: 2021 Jul 14 (Print Publication: 2021).

Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.

Autor: Tso FY; Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States of America.; School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE, United States of America., Lidenge SJ; Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States of America.; School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE, United States of America.; Ocean Road Cancer Institute, Dar es Salaam, Tanzania.; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Poppe LK; Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States of America.; School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE, United States of America., Peña PB; Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States of America.; School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE, United States of America., Privatt SR; Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States of America.; School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE, United States of America., Bennett SJ; Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States of America.; School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE, United States of America., Ngowi JR; Ocean Road Cancer Institute, Dar es Salaam, Tanzania., Mwaiselage J; Ocean Road Cancer Institute, Dar es Salaam, Tanzania.; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Belshan M; Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States of America.; Department of Medical Microbiology & Immunology, Creighton University, Omaha, NE, United States of America., Siedlik JA; Department of Exercise Science and Pre-Health Professions, Creighton University, Omaha, NE, United States of America., Raine MA; Department of Medical Microbiology & Immunology, Creighton University, Omaha, NE, United States of America., Ochoa JB; Department of Surgery, Ochsner Medical Center, New Orleans, LA, United States of America., Garcia-Diaz J; Department of Internal Medicine Ochsner Medical Center, New Orleans, LA, United States of America., Nossaman B; Department of Internal Medicine Ochsner Medical Center, New Orleans, LA, United States of America., Buckner L; Department of Internal Medicine Ochsner Medical Center, New Orleans, LA, United States of America., Roberts WM; Department of Internal Medicine Ochsner Medical Center, New Orleans, LA, United States of America., Dean MJ; Louisiana State University Cancer Center, New Orleans, LA, United States of America., Ochoa AC; Louisiana State University Cancer Center, New Orleans, LA, United States of America.; Department of Pediatrics LSU Health, New Orleans, LA, United States of America., West JT; Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States of America.; Department of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE, United States of America., Wood C; Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States of America.; School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE, United States of America.; Department of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE, United States of America.

Publikováno v: PloS one [PLoS One] 2021 Mar 04; Vol. 16 (3), pp. e0247640. Date of Electronic Publication: 2021 Mar 04 (Print Publication: 2021).

Responses to propofol in the pulmonary vascular bed of the rat.

Autor: Kaye AD, Anwar M, Banister RE, Feng CJ, Turner K, Kadowitz PJ, Nossaman BD

Publikováno v: Acta anaesthesiologica Scandinavica [Acta Anaesthesiol Scand] 1999 Apr; Vol. 43 (4), pp. 431-7.

A Dose-Response Analysis of Crystalloid Administration during Esophageal Resection.

Autor: Smith M; From the Department of Anesthesiology, Ochsner Clinic Foundation, and the Ochsner Clinical School program of the University of Queensland (Australia) School of Medicine, New Orleans, Louisiana., Nossaman B; From the Department of Anesthesiology, Ochsner Clinic Foundation, and the Ochsner Clinical School program of the University of Queensland (Australia) School of Medicine, New Orleans, Louisiana.

Publikováno v: Southern medical journal [South Med J] 2019 Jul; Vol. 112 (7), pp. 412-418.